| Matthew David Hyman Shapiro, DO | |
|
164 High St, Greenfield, MA 01301-2613 | |
| (413) 773-2263 | |
| (413) 773-2127 |
| Full Name | Matthew David Hyman Shapiro |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 164 High St, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649769050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 290220 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
| Baystate Franklin Medical Center | 9638151731 | 20 |
News Archive
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
› Verified 7 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
› Verified 7 days ago
| Entity Name | Baystate Wing Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962410233 PECOS PAC ID: 9335048321 Enrollment ID: O20040511000400 |
News Archive
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
› Verified 7 days ago
| Entity Name | Baystate Franklin Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508867391 PECOS PAC ID: 9638151731 Enrollment ID: O20040602001590 |
News Archive
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew David Hyman Shapiro, DO 280 Chestnut St Fl 2, Springfield, MA 01199-1001 Ph: (413) 794-5700 | Matthew David Hyman Shapiro, DO 164 High St, Greenfield, MA 01301-2613 Ph: (413) 773-2263 |
News Archive
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).
› Verified 7 days ago
Thomas Hagamen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High St, Greenfield, Greenfield, MA 01301 Phone: 413-773-2263 | |
Jennifer M Dohrmann, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-772-2263 Fax: 413-773-2127 | |
Dr. Lucas Charles Rosiere, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-0211 | |
Mr. Kenneth Grantland Christian Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-2263 | |
Laura Taylor Director, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-2263 Fax: 413-773-2127 | |
Dr. Michael David Dunkerley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Franklin Medical Center- Dept Of Emergency Medicine, Greenfield, MA 01301 Phone: 413-773-2581 | |
Nathan T Wilson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High Street, Greenfield, MA 01301 Phone: 413-773-2263 |